Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Adept Neuro is a Swiss neurotechnology medical device company formed as a joint venture between DIXI Medical and Aleva Neurotherapeutics to develop next-generation intracerebral stereoelectroencephalography (SEEG) electrodes for epilepsy surgery. Its products are designed to support localization of epileptogenic zones and enable thermocoagulation during neurosurgical procedures. The company leverages Aleva's MEMS microfabrication know-how together with DIXI's manufacturing and distribution capabilities in intracerebral electrodes. Adept Neuro appears to have remained an active legal entity after DIXI moved toward sole ownership, and it is best characterized as an epilepsy-focused implantable device developer rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Adept Neuro.